抗缪勒氏管激素在生殖领域中的相关应用
Relevant Application of Anti-Mullerian Hormone in Reproductive Field
摘要: 抗缪勒氏管激素(anti-mullerian hormone, AMH)是转化生长因子-β超家族成员之一，主要由卵巢的颗粒细胞分泌。近年来随着人们对AMH研究的深入，提议将AMH作为多囊卵巢综合征的诊断标准之一，AMH在生殖领域的作用越来越广泛。AMH在预测绝经年龄、评估卵巢储备等方面发挥重要作用，最新提出使用AMH来评价卵母细胞质量、胚胎质量及妊娠结局。本文旨在探讨血清AMH对卵泡发育、多囊卵巢综合征(polycystic ovarian syndrome, PCOS)诊断及其辅助生殖方面的应用价值。
Abstract: Anti-Mullerian hormone (AMH) is one of the transformed growth factor-β superfamily members and is secreted by ovarian granulosa cells. With development of further research of AMH, it was pro-posed as one of the diagnosis of polycystic ovarian syndrome, and the role of AMH in the reproduc-tive field is more extensive in recent years. AMH plays an important role in predicting menopausal age and evaluating ovarian reserve. AMH has recently been proposed to evaluate oocyte quality, embryo quality and pregnancy outcome. The purpose of this study is to discuss the application val-ue of serum AMH in follicular development, polycystic ovarian syndrome (PCOS) diagnosis and as-sisted reproductive technology.
文章引用：刘利君, 李泽武, 陈亚楠, 顾玉婷, 石城, 杨爱军. 抗缪勒氏管激素在生殖领域中的相关应用[J]. 临床医学进展, 2022, 12(8): 7053-7058. https://doi.org/10.12677/ACM.2022.1281015

参考文献

[1] Homburg, R. and Crawford, G. (2014) The Role of AMH in Anovulation Associated with PCOS: A Hypothesis. Hu-man Reproduction, 29, 1117-1121. [Google Scholar] [CrossRef] [PubMed]
[2] Sathyapalan, T., Al-Qaissi, A., Kilpatrick, E.S., et al. (2018) Anti-Mullerian Hormone Measurement for the Diagnosis of Polycystic Ovary Syndrome. Clinical Endocrinology, 88, 258-262. [Google Scholar] [CrossRef] [PubMed]
[3] Sonigo, C., Beau, I., Grynberg, M. and Binart, N. (2019) AMH Prevents Primordial Ovarian Follicle Loss and Fertility Alteration in Cyclophospha-mide-Treated Mice. The FASEB Journal, 33, 1278-1287. [Google Scholar] [CrossRef] 
[4] Yang, M.Y., Cushman, R.A. and Fortune, J.E. (2017) Anti-Mullerian Hormone Inhibits Activation and Growth of Bovine Ovarian Follicles in Vitro and Is Localized to Growing Follicles. Molecular Human Reproduction, 23, 282-291. [Google Scholar] [CrossRef] [PubMed]
[5] Ilha, G.F., Rovani, M.T., Gasperin, B.G., et al. (2016) Regulation of Anti-Mullerian Hormone and Its Receptor Expression around Follicle Deviation in Cattle. Reproduction in Domestic Animals, 51, 188-194. [Google Scholar] [CrossRef] [PubMed]
[6] Alipour, F., Rasekhjahromi, A., Maalhagh, M., et al. (2015) Comparison of Specificity and Sensitivity of AMH and FSH in Diagnosis of Premature Ovarian Failure. Disease Markers, 2015, Article ID: 585604. [Google Scholar] [CrossRef] [PubMed]
[7] Dewailly, D., Andersen, C.Y., Balen, A., et al. (2014) The Physiology and Clinical Utility of Anti-Mullerian Hormone in Women. Human Reproduction Update, 20, 370-385. [Google Scholar] [CrossRef] [PubMed]
[8] Dumont, A., Robin, G. and Dewailly, D. (2018) Anti-Mullerian Hormone in the Pathophysiology and Diagnosis of Polycystic Ovarian Syndrome. Current Opinion in Endocrinology, Diabetes and Obesity, 25, 377-384. [Google Scholar] [CrossRef] 
[9] Pigny, P., Jonard, S., Robert, Y. and Dewailly, D. (2006) Serum Anti-Mullerian Hormone as a Surrogate for Antral Follicle Count for Definition of the Polycystic Ovary Syn-drome. The Journal of Clinical Endocrinology & Metabolism, 91, 941-945. [Google Scholar] [CrossRef] [PubMed]
[10] Asanidze, E., Kristesashvili, J., Pkhaladze, L. and Khomasuridze, A. (2019) The Value of Anti-Mullerian Hormone in the Management of Polycystic Ovary Syndrome in Adolescents. Gyne-cological Endocrinology, 35, 974-977. [Google Scholar] [CrossRef] [PubMed]
[11] Bhide, P., Dilgil, M., Gudi, A., et al. (2015) Each Small Antral Follicle in Ovaries of Women with Polycystic Ovary Syndrome Produces More Antimullerian Hormone than Its Counterpart in a Normal Ovary: An Observational Cross- Sectional Study. Fertility and Sterility, 103, 537-541. [Google Scholar] [CrossRef] [PubMed]
[12] Evliyaoglu, O., Imöhl, M., Weiskirchen, R. and van Helden, J. (2020) Age-Specific Reference Values Improve the Diagnostic Performance of AMH in Polycystic Ovary Syndrome. Clinical Chemistry and Laboratory Medicine, 58, 1291-1301. [Google Scholar] [CrossRef] [PubMed]
[13] Shi, X., Peng, D., Liu, Y., et al. (2019) Advantages of Serum Anti-Mullerian Hormone as a Marker for Polycystic Ovarian Syndrome. Laboratory Medicine, 50, 236-242. [Google Scholar] [CrossRef] [PubMed]
[14] Sova, H., Unki-la-Kallio, L., Tiitinen, A., et al. (2019) Hormone Profiling, Including Anti-Mullerian Hormone (AMH), for the Diagnosis of Polycystic Ovary Syndrome (PCOS) and Characterization of PCOS Phenotypes. Gynecological Endocrinology, 35, 595-600. [Google Scholar] [CrossRef] [PubMed]
[15] Recabarren, S.E., Smith, R., Rios, R., et al. (2008) Metabolic Profile in Sons of Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metab-olism, 93, 1820-1826. [Google Scholar] [CrossRef] [PubMed]
[16] Detti, L., Christiansen, M.E., Francillon, L., et al. (2019) Serum Anti-Mullerian Hormone (AMH) in Mothers with Polycystic Ovary Syndrome (PCOS) and Their Term Fetuses. Systems Biology in Reproductive Medicine, 65, 147-154. [Google Scholar] [CrossRef] [PubMed]
[17] Valgeirsdottir, H., Vanky, E., Sundström-Poromaa, I., et al. (2019) Prenatal Exposures and Birth Indices, and Subsequent Risk of Polycystic Ovary Syndrome: A National Regis-try-Based Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology, 126, 244-251. [Google Scholar] [CrossRef] [PubMed]
[18] Tehrani, F.R., Yarandi, R.B., Solaymani-Dodaran, M., et al. (2020) Improving Prediction of Age at Menopause Using Multiple Anti-Mullerian Hormone Measurements: The Tehran Li-pid-Glucose Study. The Journal of Clinical Endocrinology & Metabolism, 105, 1589-1598. [Google Scholar] [CrossRef] [PubMed]
[19] Tehrani, F.R., Solaymani-Dodaran, M. and Azizi, F. (2009) A Single Test of Antimullerian Hormone in Late Reproductive-Aged Women Is a Good Predictor of Menopause. Menopause, 16, 797-802. [Google Scholar] [CrossRef] 
[20] Kruszynska, A. and Slowinska-Srzednicka, J. (2017) An-ti-Mullerian Hormone (AMH) as a Good Predictor of Time of Menopause. Przeglad Menopauzalny, 16, 47-50. [Google Scholar] [CrossRef] [PubMed]
[21] Forslund, M., Landin-Wilhelmsen, K., Schmidt, J., et al. (2019) Higher Menopausal Age but No Differences in Parity in Women with Polycystic Ovary Syndrome Compared with Con-trols. Acta Obstetricia et Gynecologica Scandinavica, 98, 320-326. [Google Scholar] [CrossRef] [PubMed]
[22] Minooee, S., Tehrani, F.R., Rahmati, M., et al. (2018) Prediction of Age at Menopause in Women with Polycystic Ovary Syndrome. Climacteric, 21, 29-34. [Google Scholar] [CrossRef] [PubMed]
[23] Depmann, M., Eijkemans, M.J.C., Broer, S.L., et al. (2017) How Well Does AMH Relate to Timing of Menopause? Results of an Individual Patient Data Meta-Analysis. Maturitas, 100, 201. [Google Scholar] [CrossRef] 
[24] Aydogan, B. and Mirkin, S. (2015) The Utility of Measuring Anti-Mullerian Hormone in Predicting Menopause. Climacteric, 18, 777-789. [Google Scholar] [CrossRef] [PubMed]
[25] Pilsgaard, F., Grynnerup, A.G.A., Løssl, K., et al. (2018) The Use of Anti-Mullerian Hormone for Controlled Ovarian Stimulation in Assisted Reproductive Technology, Fertility Assessment and -Counseling. Acta Obstetricia et Gynecologica Scandinavica, 97, 1105-1113. [Google Scholar] [CrossRef] [PubMed]
[26] Peuranpaa, P., Hautamäki, H., Halttunen-Nieminen, M., et al. (2020) Low Anti-Mullerian Hormone Level Is Not a Risk Factor for Early Pregnancy Loss in IVF/ICSI Treatment. Human Repro-duction, 35, 504-515. [Google Scholar] [CrossRef] [PubMed]
[27] Borges, E., Braga, D., Setti, A., et al. (2017) The Predictive Value of Serum Concentrations of Anti-Mullerian Hormone for Oocyte Quality, Fertilization, and Implantation. JBRA Assisted Reproduction, 21, 176-182. [Google Scholar] [CrossRef] [PubMed]
[28] Siddiqui, Q.A., Anjum, S., Zahra, F., et al. (2019) Ovarian Re-serve Parameters and Response to Controlled Ovarian Stimulation in Infertile Patients. Pakistan Journal of Medical Sci-ences, 35, 958-962. [Google Scholar] [CrossRef] [PubMed]
[29] Pacchiarotti, A., Iaconianni, P., Caporali, S., et al. (2020) Severe En-dometriosis: Low Value of AMH Did Not Affect Oocyte Quality and Pregnancy Outcome in IVF Patients. European Review for Medical and Pharmacological Sciences, 24, 11488-11495.
[30] Goswami, M. and Nikolaou, D. (2017) Is AMH Level, Independent of Age, a Predictor of Live Birth in IVF? Journal of Human Reproductive Sciences, 10, 24-30.
[31] Ligon, S., Lustik, M., Levy, G. and Pier, B. (2019) Low Antimullerian Hormone (AMH) Is Associated with Decreased Live Birth after in Vitro Fertilization When Follicle-Stimulating Hormone and AMH Are Discordant. Fertility and Sterility, 112, 73-81.E1. [Google Scholar] [CrossRef] [PubMed]
[32] Umarsingh, S., Adam, J.K. and Krishna, S. (2020) The Relationship between Anti-Müllerian Hormone (AMH) Levels and Pregnancy Outcomes in Pa-tients Undergoing Assisted Reproductive Techniques (ART). PeerJ, 8, e10390. [Google Scholar] [CrossRef] [PubMed]
[33] Ciepiela, P., Dulęba, A.J., Kario, A., et al. (2019) Oocyte Matched Follic-ular Fluid Anti-Mullerian Hormone Is an Excellent Predictor of Live Birth after Fresh Single Embryo Transfer. Human Reproduction, 34, 2244-2253. [Google Scholar] [CrossRef] [PubMed]
[34] Dai, X., Wang, Y., Yang, H., et al. (2020) AMH Has No Role in Predicting Oocyte Quality in Women with Advanced Age Undergoing IVF/ICSI Cycles. Scientific Reports, 10, Article No. 19750. [Google Scholar] [CrossRef] [PubMed]

为你推荐